Odin PharmaOdintropin 100IU
| Quantity | Discount | Price |
|---|---|---|
| 3–5 | 10% | $459,00 |
| 6–9 | 15% | $433,50 |
| 10–100 | 20% | $408,00 |
Specifications
- Brand: Odin Pharma Peptides & SARMs
- Substance: Human Growth Hormone
- Product Form: Powder
- Dosage: 100IU
How To Use
Laboratory Preparation & Research Dosing Protocols
Disclaimer: The following information is for educational and laboratory reference only. This product is strictly for in-vitro and in-vivo research and is not intended for human consumption or therapeutic use.
This kit contains 100 IU of lyophilized Recombinant Human Growth Hormone powder. Careful handling and precision measurement are critical for accurate data collection.
Reconstitution Guide
For standard research concentration, reconstitute the 100 IU vial with 1 ml to 5 ml of Bacteriostatic Water (e.g., 5 ml allows for exact and easy concentration math).
- Preparation: Slowly inject the water against the glass wall of the vial.
- Dissolution: Swirl gently until clear. Do not shake, as the large peptide structure is highly sensitive to mechanical stress.
- Measurement Reference (Using 5 ml dilution with a U-100 insulin syringe):
- 5 Units on the syringe = 1 IU
- 10 Units on the syringe = 2 IU
- 25 Units on the syringe = 5 IU
Storage Specifications
- Unmixed (Lyophilized): Store in a cool, dry place (2°C to 8°C). For long-term preservation, store at -20°C.
- Mixed (Reconstituted): Must be refrigerated (2°C to 8°C). Use within 14-21 days for maximum analytical integrity.
Experience Level Usage Guide
Beginner
Baseline Anabolic/Lipolytic Model
Reference dosing for initial studies investigating the modulation of basal metabolic rate and early tolerance.
- Test Subject Dosage: 1.0 IU to 2.0 IU per administration.
- Frequency: Administered as a daily subcutaneous or intramuscular injection (typically away from caloric windows).
- Research Aim: Assessment of subject tolerance and early lipid/glucose metabolism markers.
Intermediate
Advanced Protein Turnover Evaluation Model
Standard dosage for evaluating the long-term impact of somatotropic signaling on body composition.
- Test Subject Dosage: 2.0 IU to 4.0 IU per day (can be split into morning and evening administrations).
- Frequency: Administered daily.
- Observation Period: 4 to 8 weeks for longitudinal data collection.
Advanced
The Regenerative Tissue Synergy Stack
Advanced protocol investigating the synergy between systemic anabolism and targeted soft-tissue repair.
- The Stack: Odintropin (2.0 IU daily) + BPC-157 (250 mcg twice daily).
- Scientific Rationale: Investigates the combined impact of systemic protein synthesis and lipolysis (HGH) alongside targeted soft-tissue and vascular healing (BPC-157).
- Frequency: Combined daily schedule according to study objectives.
Shipping Details
Detailed Description
What Is Odin Pharma Odintropin 100 IU?
Odin Pharma Odintropin 100 IU is a highly purified, synthetic recombinant Human Growth Hormone (rHGH). Characterized by its precise 191-amino acid sequence, it perfectly mirrors the endogenous somatropin produced by the human pituitary gland. In the scientific community, it is highly sought after for its powerful capacity to stimulate widespread cellular hyperplasia, dramatically upregulate hepatic IGF-1 output, and facilitate rapid musculoskeletal repair. This comprehensive 100 IU lyophilized kit is an essential instrument for high-precision USA domestic research facilities conducting advanced longitudinal studies on tissue regeneration, metabolic shifts, and anti-aging biological markers.
If your laboratory protocols involve exploring the absolute maximum threshold of structural tissue recovery or metabolic fat oxidation, you can buy peptides and premium biological compounds of this analytical grade through our Muscle Growth Peptides & SARMs category.
Important: Odin Pharma Odintropin 100 IU is strictly for laboratory research and is not intended for human consumption or therapeutic use.
Odin Pharma Odintropin 100 IU: Technical Profile
| Scientific Parameter | Details for Odin Pharma Odintropin |
|---|---|
| Compound Category | Recombinant Human Growth Hormone (Somatropin) |
| Total Concentration | 100 IU Total Yield (Lyophilized Powder) |
| Mechanism Focus | Direct Somatotropic Receptor Agonism & Hepatic IGF-1 Amplification |
Research Benefits of Odin Pharma Odintropin 100 IU
In controlled laboratory settings, it is valued for its raw biological potency and clean regenerative profile. Key research benefits include:
- Structural Tissue Hyperplasia: Studying the direct stimulation of chondrocytes and osteoblasts, resulting in the rapid repair and densification of cartilage, bone, and connective tissues.
- IGF-1 Amplification: Investigating its powerful action on the liver to synthesize and release Insulin-Like Growth Factor 1, the primary endocrine driver of cellular division.
- Accelerated Lipid Oxidation: Researching the compound’s ability to trigger intense lipolysis, efficiently mobilizing and clearing visceral adipose tissue in metabolic and obesity models.
- Anti-Aging & Nitrogen Retention: Exploring how Odintropin restores a youthful positive nitrogen balance and combats cellular senescence in aging test subjects.
How Does Odin Pharma Odintropin 100 IU Work?
The mechanism ofOdintropin 100 IU relies on introducing active, exogenous somatropin directly into the subject’s systemic circulation, entirely bypassing the need for natural pituitary stimulation. The 191-amino acid chain binds directly to growth hormone receptors distributed across various tissues, heavily activating the JAK2/STAT5 signaling pathway. This transcription cascade instructs the cells to initiate protein synthesis, divide, and rapidly regenerate. Because Peptidesline provides vacuum-sealed, analytical-grade Odin Pharma products, researchers can reliably track these massive physiological shifts with high experimental accuracy.
Potential Side Effects in Research Models
Researchers utilizingOdintropin 100 IU must monitor for physiological responses associated with its profound somatotropic activity:
- Fluid Homeostasis: Significant water retention or extracellular edema is commonly observed during the initial dose-escalation phase of an assay.
- Insulin Resistance: Exogenous growth hormone strongly opposes the action of insulin; researchers frequently observe transient but notable increases in fasting blood glucose levels.
- Soft Tissue Expansion: Rapid expansion of soft tissues can lead to nerve compression, mimicking carpal-tunnel syndrome in animal models.
- Organ Hypertrophy: In very high-dose, long-term studies, generalized growth of internal organs may be observed due to elevated systemic IGF-1.
Odintropin vs. Secretagogues & Analogs
| Research Agent | Targeted Action | Main Research Strength |
|---|---|---|
| CJC-1295 / Ipamorelin | Pituitary Secretagogue Blend | Stimulates the pituitary to naturally raise endogenous GH over time while maintaining the negative feedback loop. |
| IGF-1 LR3 | IGF-1 Receptor Agonist | Directly induces severe cellular hyperplasia, bypassing the liver entirely, but lacks the fat-burning effects of HGH. |
| Odintropin 100 IU | Direct Recombinant HGH | Delivers active somatropin directly to the system, ensuring maximum biological impact regardless of pituitary health. |
Buy Odin Pharma Odintropin 100 IU Online
When conducting critical tissue regeneration or longitudinal metabolic assays, Peptidesline is your reliable source for batch-certified compounds. OurOdintropin 100 IU kits are verified for 100% biological integrity.
- Express USA Delivery: Fast shipping to your research facility in 4-7 business days.
- Secure Checkout: Simple payment options via Zelle or Venmo.
- 10% Crypto Discount: Unlock a 10% discount on Odintropin 100 IU by paying with Bitcoin or USDT.
- Click here for Payment Options
FAQ
Researchers should regularly monitor systemic IGF-1 levels to confirm the hepatic response to the exogenous somatropin. Additionally, tracking fasting blood glucose and HbA1c is critical, as high doses of HGH can induce transient insulin resistance in test models.
Unlike localized peptides like BPC-157 which rely on angiogenesis, Odintropin works systemically to increase IGF-1. This directly stimulates chondrocytes (cartilage cells) to synthesize new collagen and structural matrix, making it superior for widespread, severe joint degradation models.
While regular sterile water will dissolve the lyophilized powder, it lacks the 0.9% benzyl alcohol preservative. If sterile water is used, the reconstituted Odintropin must be utilized completely within 24 to 48 hours to prevent bacterial degradation. Bacteriostatic water extends this viability to roughly 21-30 days.
Lyophilized (freeze-dried) somatropin is vastly more stable than pre-mixed liquid pens when kept in a frozen state (-20°C). This allows facilities utilizing Peptidesline to purchase bulk 100 IU kits and store them for months or years without any loss of biological potency prior to the start of an assay.
Yes, introducing high levels of exogenous somatropin triggers the body's natural negative feedback loop via somatostatin. This effectively suppresses the pituitary gland's endogenous production of growth hormone for the duration of the testing protocol.
Odintropin is 191-aa, which is bio-identical to human GH. 192-aa versions contain an extra amino acid that can cause the body to develop antibodies, making the GH useless over time.
Yes, it triggers lipolysis, which breaks down triglycerides into free fatty acids to be used as energy, specifically targeting subcutaneous fat.
